Infection and Inflammation Imaging: Beyond FDG
Authors
Affiliations
This review discusses nuclear imaging of inflammation using molecular probes beyond fluoro-d-glucose, is structured by cellular targets, and focuses on those tracers that have been successfully applied clinically.
The promise and reality of new immune profiling technologies.
Suliman S, Maison D, Henrich T Nat Immunol. 2024; 25(10):1765-1769.
PMID: 39242838 DOI: 10.1038/s41590-024-01948-0.
Grandjean C, Pedersen S, Christensen C, Dibenedetto A, Eriksen T, Binderup T Sci Rep. 2023; 13(1):9249.
PMID: 37286582 PMC: 10247730. DOI: 10.1038/s41598-023-35302-5.
Cold Kit Labeling: The Future of Ga Radiopharmaceuticals?.
Lepareur N Front Med (Lausanne). 2022; 9:812050.
PMID: 35223907 PMC: 8869247. DOI: 10.3389/fmed.2022.812050.
In Vivo Targeting of CXCR4-New Horizons.
Schottelius M, Herrmann K, Lapa C Cancers (Basel). 2021; 13(23).
PMID: 34885030 PMC: 8656854. DOI: 10.3390/cancers13235920.
Linz C, Brands R, Kertels O, Dierks A, Brumberg J, Gerhard-Hartmann E Eur J Nucl Med Mol Imaging. 2021; 48(12):3951-3960.
PMID: 34050405 PMC: 8484183. DOI: 10.1007/s00259-021-05422-z.